Former marketing executive with Toshiba Medical and GE Healthcare. He was recognized as the driving force behind highly successful marketing strategies that resulted in 10-fold growth in market share, record-breaking revenue growth and #1 user satisfaction ratings. Mr. Zimmer has presented at national conferences, published articles and served as a guest lecturer on technological advancements. He also secured and managed relationships with luminary accounts and KOL physicians that were recognized as the top global producers of peer-reviewed publications. Mr. Zimmer will help form strategic alliances regarding embedded applications of our software in clinical imaging systems. He is an expert on product commercialization, sales and marketing, and advises Insilicomed in these areas.
Natalie Kennel, RAC, ASQ CQE & CQMgr
Ms. Kennel founded a medical device consultancy, to bring her practical perspective to medical device quality and regulatory affairs. With more than 25 years experience in industry, she has expertise with development, manufacturing and Regulatory Affairs/Quality Assurance (RA/QA), as well as having served in clinical roles in both major and start up medical device companies. Ms. Kennel has managed numerous FDA regulatory submissions, and for the past 12 years she has taught the medical device submission section for the U.S. RAC study group, and regularly teaches a software validation seminar for the USC regulatory affairs master’s program. Ms. Kennel assists Insilicomed with FDA regulatory planning. She also assists with pre-submissions and full submissions to FDA.
Retired Vice President of Technology Policy and Academic Relations, Medtronic. Senior fellow at the von Liebig Center, School of Engineering, University of California San Diego. Adjunct Professor of Bioengineering at UCSD. Mr. Citron is advising Insilicomed on developing business relations with major medical device companies.
Andrew McCulloch, PhD
Co-founder, Insilicomed, Inc., principal author of Continuity software platform licensed exclusively by Insilicomed from the University of California, Professor and former Chair of Bioengineering, UC San Diego, Adjunct Professor of Medicine at UC San Diego, Jacobs Distinguished Scholar; Co-Director, Cardiac Mechanics Research Group (CMRG) at UC San Diego; Co-Director, Cardiac Biomedical Science and Engineering Center, more than 25 years experience in research and teaching in cardiac mechanics, electrophysiology and cellular dynamics. Basic research on cardiac electrophysiology and mechanics; expert in computational modeling of cardiac function.
Jeff Omens, PhD
Co-founder, Insilicomed, Inc., expert in cardiac function and heart disease, large animal experimentation and planning, instrumentation, uses of advanced simulations of cardiac electrophysiology and mechanics. Basic research on cardiac function and bioengineering; Professor of Medicine and Bioengineering at UC San Diego; Co-Director, CMRG at UC San Diego.
Anthony DeMaria, MD
Professor of Medicine (Cardiology), University of California, San Diego
Director, UCSD Cardiovascular Center, international expert in cardiac imaging including echocardiography and intravascular ultrasound. Dr. DeMaria has received numerous awards and is listed in The Best Doctors in America. He served as a member of the Subspecialty Board on Cardiovascular Disease for the American Board of Internal Medicine from 1991 to 1997. He is the Editor of the Journal of American College of Cardiology and Echocardiography. He serves on the Editorial Boards and acts as Editorial Consultant for almost thirty medical journals. Dr. DeMaria advises Insilicomed on the uses and interpretation of clinical data and the design of clinical studies.
James C. Perry, MD
Professor of Pediatrics (Cardiology), University of California San Diego, Director of Electrophysiology and Adult Congenital Heart Programs, Rady Children’s Hospital San Diego. Dr. Perry is an internationally recognized leader in clinical congenital electrophysiology and heart disease. He has also led product development efforts with cardiac rhythm management companies over 25 years and was Chief Scientific Officer of Teknion Heart, a start-up targeting novel pacing and defibrillation configurations for young patients. He is past president of the Pediatric EP Society, a member and consultant to many editorial boards and former Chief of Pediatric Cardiology at both Rady Children’s and Yale University. He is currently working at UCSD with Dr. Andrew McCulloch’s lab on computational models of congenital heart disease and with Dr. Alison Marsden’s group on fluid dynamics of congenital heart disease and pacing. He will provide input to Insilicomed on development and interpretation of novel translational efforts in cardiac simulation.